Alzheimer's drug cited as Medicare premium jumps by $21.60
The Biogen Inc., headquarters is shown March 11, 2020, in Cambridge, Mass. Medicare's “Part B” outpatient premium will jump by $21.60 next year, one of the largest increases ever. Medicare officials told reporters on Friday, Nov. 12, 2021, that about half the increase is attributable to contingency planning if the program has to cover Aduhelm, a new $56,000-a-year medication for Alzheimer's disease made by Biogen. (AP Photo/Steven Senne, File)/ WASHINGTON (AP) — Medicare's “Part B” outpatient premium will jump by $21.60 a month in 2022, one ...
Click
To Read Full Article
